Form 4: Shuttle Pharmaceuticals Director Sells Shares to Cover Tax Obligations

Director Chris Senanayake sold 1,626 shares of Shuttle Pharmaceuticals Holdings, Inc. to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On December 29, 2022, Chris Senanayake, a director of Shuttle Pharmaceuticals Holdings, Inc., sold 1,626 shares of common stock at a price of $1.605 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of 4,417 restricted stock units (RSUs).
• Following the transaction, Senanayake directly owns 2,791 shares of SHPH common stock.
• The sale was a non-discretionary transaction mandated by the issuer under its equity incentive plan.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and directors.

Key Dates

Keywords

Form 4, SEC, Shuttle Pharmaceuticals Holdings, SHPH, Chris Senanayake, Stock Sale, Director, Restricted Stock Units, Tax Withholding